
Drug firm Zydus Cadila on Wednesday said it has started human clinical trials of its COVID-19 vaccine candidate ZyCoV-D. In the phase of trials, the company will be enrolling over 1,000 subjects across multiple clinical study sites in India.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/30bfDd5
via
IFTTT
0 comments:
Post a Comment